Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Hits New 12-Month Low – Here’s Why

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) shares reached a new 52-week low on Wednesday . The company traded as low as $4.94 and last traded at $4.97, with a volume of 2844941 shares. The stock had previously closed at $5.21.

Wall Street Analyst Weigh In

Separately, Bank of America raised shares of Bayer Aktiengesellschaft from an “underperform” rating to a “neutral” rating in a research note on Friday, September 6th. One research analyst has rated the stock with a sell rating and six have issued a hold rating to the stock. Based on data from MarketBeat.com, Bayer Aktiengesellschaft presently has an average rating of “Hold”.

Bayer Aktiengesellschaft Trading Up 1.6 %

The stock has a fifty day simple moving average of $6.83 and a 200-day simple moving average of $7.24. The company has a current ratio of 1.27, a quick ratio of 0.86 and a debt-to-equity ratio of 1.04.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.10). Bayer Aktiengesellschaft had a positive return on equity of 16.46% and a negative net margin of 2.02%. The firm had revenue of $10.96 billion for the quarter. As a group, equities analysts predict that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.